Skip to main content

Katie Herman

Conference Coverage
10/01/2022
At the 2022 ASCO Quality Care Symposium, Ives and colleagues concluded that therapeutic interchange is an effective way to reduce total cost of care while maintaining the quality of care in the Oncology Care Model.
At the 2022 ASCO Quality Care Symposium, Ives and colleagues concluded that therapeutic interchange is an effective way to reduce total cost of care while maintaining the quality of care in the Oncology Care Model.
At the 2022 ASCO Quality Care...
10/01/2022
Journal of Clinical Pathways
Conference Coverage
12/12/2022
At the 64th ASH Annual Meeting and Exposition, Gunjan L Shah, MD, described and compared hospital costs and health care resource utilization of chimeric antigen T-cell therapy and stem cell transplant for the procedure, preprocedure, and...
At the 64th ASH Annual Meeting and Exposition, Gunjan L Shah, MD, described and compared hospital costs and health care resource utilization of chimeric antigen T-cell therapy and stem cell transplant for the procedure, preprocedure, and...
At the 64th ASH Annual Meeting...
12/12/2022
Journal of Clinical Pathways
Conference Coverage
10/15/2022
Kjel A. Johnson, PharmD, Vice President, Specialty Product Strategy CVS Health, presented at the 2022 Oncology Clinical Pathways Congress regarding optimizing patient care in older adults from an operational and integrational perspective.
Kjel A. Johnson, PharmD, Vice President, Specialty Product Strategy CVS Health, presented at the 2022 Oncology Clinical Pathways Congress regarding optimizing patient care in older adults from an operational and integrational perspective.
Kjel A. Johnson, PharmD, Vice...
10/15/2022
Journal of Clinical Pathways
Conference Coverage
12/09/2022
Daniel Peiffer, MD, PhD, and colleagues discuss a retrospective cohort study comparing clinical characteristics and demographics of HER2-0 vs HER2-low cases.
Daniel Peiffer, MD, PhD, and colleagues discuss a retrospective cohort study comparing clinical characteristics and demographics of HER2-0 vs HER2-low cases.
Daniel Peiffer, MD, PhD, and...
12/09/2022
Journal of Clinical Pathways
Conference Coverage
10/16/2022
Tatjana Kolevska, MD, explains at the 2022 Oncology Clinical Pathways Conference that digital pathways are the way of the future in regard to cancer care.
Tatjana Kolevska, MD, explains at the 2022 Oncology Clinical Pathways Conference that digital pathways are the way of the future in regard to cancer care.
Tatjana Kolevska, MD, explains...
10/16/2022
Journal of Clinical Pathways
Conference Coverage
10/16/2022
Tushar Pandey, CEO, SimBioSys, Inc, in his 2022 Oncology Clinical Pathways Congress presented on the value artificial intelligence brings to oncology patient care, and the need to move to guided intelligence.
Tushar Pandey, CEO, SimBioSys, Inc, in his 2022 Oncology Clinical Pathways Congress presented on the value artificial intelligence brings to oncology patient care, and the need to move to guided intelligence.
Tushar Pandey, CEO, SimBioSys,...
10/16/2022
Journal of Clinical Pathways
Conference Coverage
12/07/2022
Della Varghese, PharmD, PhD, and colleagues presented a poster at the 2022 San Antonio Breast Cancer Symposium studying second-line (2L) treatment patterns and outcomes among HER2+ metastatic breast cancer (mBC) patients in the United States.
Della Varghese, PharmD, PhD, and colleagues presented a poster at the 2022 San Antonio Breast Cancer Symposium studying second-line (2L) treatment patterns and outcomes among HER2+ metastatic breast cancer (mBC) patients in the United States.
Della Varghese, PharmD, PhD, and...
12/07/2022
Journal of Clinical Pathways
Conference Coverage
10/16/2022
Mahek Shah, MD, MBA, MS, at the 2022 Oncology Clinical Pathways Congress, discussed the need to enable gene sequencing-as-a-service in clinical settings and what that means for future clinical care.
Mahek Shah, MD, MBA, MS, at the 2022 Oncology Clinical Pathways Congress, discussed the need to enable gene sequencing-as-a-service in clinical settings and what that means for future clinical care.
Mahek Shah, MD, MBA, MS, at the...
10/16/2022
Journal of Clinical Pathways
Conference Coverage
10/18/2022
Matthew A Lunning, DO, FACP, Associate Professor, Fred & Pamela Buffett Cancer Center, Associate Vice-Chair of Research Department of Medicine, Assistant Vice Chancellor of Clinical Research, University of Nebraska Medical Center, Omaha,...
Matthew A Lunning, DO, FACP, Associate Professor, Fred & Pamela Buffett Cancer Center, Associate Vice-Chair of Research Department of Medicine, Assistant Vice Chancellor of Clinical Research, University of Nebraska Medical Center, Omaha,...
Matthew A Lunning, DO, FACP,...
10/18/2022
Journal of Clinical Pathways
Conference Coverage
12/07/2022
Andre Mattar, MD, PhD, and colleagues presented their study at the 2022 San Antonio Breast Cancer Symposium demonstrating significant differences between HER2-low and other cancer subtypes in breast cancer patients.
Andre Mattar, MD, PhD, and colleagues presented their study at the 2022 San Antonio Breast Cancer Symposium demonstrating significant differences between HER2-low and other cancer subtypes in breast cancer patients.
Andre Mattar, MD, PhD, and...
12/07/2022
Journal of Clinical Pathways